{"count": 1, "results": [{"_id": "8937934", "pmid": 8937934, "title": "Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.", "journal": "Int J Clin Pharmacol Ther", "authors": ["Erley CM", "Klass M", "Krämer D", "Berger E", "Heyne N", "Braun N", "Wolf S", "Risler T"], "date": "1996-11-01T00:00:00Z", "meta_date_publication": "1996 Nov", "meta_volume": "34", "meta_issue": "11", "meta_pages": "504-9", "score": 50068.34, "text_hl": "A prospective double-blind, randomized study was conducted to compare the effects of the @GENE_MS4A1 @GENE_931 @@@beta 1@@@ antagonist, @GENE_IGKV5_2 @GENE_28907 @@@beta 2@@@ agonist @CHEMICAL_Celiprolol @CHEMICAL_MESH:D017272 @@@celiprolol@@@ (200 mg daily) on renal hemodynamics and protein excretion with those of the @GENE_MS4A1 @GENE_931 @@@beta 1@@@ antagonist @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (50 mg daily), the @GENE_AP2B1 @GENE_163 @@@ACE-@@@inhibitor @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@ (2.5 mg daily), and placebo in 11 @SPECIES_9606 @@@patients@@@ with @DISEASE_Proteinuria @DISEASE_MESH:D011507 @@@proteinuria@@@ > 400 mg/24 h due to @<m>DISEASE_Glomerulonephritis</m> @DISEASE_MESH:D005921 @@@chronic glomerulonephritis@@@. ", "citations": {"NLM": "Erley CM, Klass M, Krämer D, Berger E, Heyne N, Braun N, Wolf S, Risler T. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis. Int J Clin Pharmacol Ther. 1996 Nov;34(11):504-9. PMID: 8937934", "BibTeX": "@article{8937934, title={Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.}, author={Erley CM and Klass M and Krämer D and Berger E and Heyne N and Braun N and Wolf S and Risler T}, journal={Int J Clin Pharmacol Ther}, volume={34}, number={11}, pages={504-9}}"}}]}